The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks
Open accessAbstract
Objective: To develop models for prediction of pre‐eclampsia (PE) based on maternal factors and biophysical and biochemical markers at 11–13 weeks' gestation. Methods: Screening study of singleton pregnancies at 11–13 weeks including 752 (2.2%) that subsequently developed PE and 32 850 that were unaffected by PE. Models were developed for the prediction of early PE, requiring delivery before 34 weeks, intermediate PE with delivery at 34–37 weeks and late PE delivering after 37 weeks. The data used for the models were firstly, maternal characteristics and history, uterine artery pulsatility index, mean arterial pressure and serum pregnancy‐associated plasma protein‐A obtained from the screening study and secondly, maternal serum or plasma concentration of placental growth factor, placental protein‐13, inhibin‐A, activin‐A, soluble endoglin, pentraxin‐3 and P‐selectin obtained from case‐control studies. Results: In screening for PE by maternal factors only at a fixed false positive rate of 5%, the estimated detection rates were 33.0% for early PE, 27.8% for intermediate PE and 24.5% for late PE. The respective detection rates in screening by a combination of maternal factors, biophysical and biochemical markers were 91.0, 79.4 and 60.9%. Conclusions: Effective prediction of PE can be achieved at 11–13 weeks' gestation. Copyright © 2011 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008
(2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02847.x · Cited by 2,994
Brown, M. A., Lindheimer, M. D., Swiet, M. D., Assche, A. V., & Moutquin, J.-M. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894
Snijders, R., Noble, P., Sebire, N., Souka, A., & Nicolaides, K. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11280-6 · Cited by 1,572 · cited 1×
“…history and perform combined screening for aneuploidies by measurement of the fetal crown-rump length (CRL) and nuchal translucency (NT) thickness and maternal serum PAPP-A and free β-human chorionic gonadotrophin (β-hCG) (Robinson and Fleming, 1975; Snijders et al., 1998; Kagan et al., 2008a).”
A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS
Robinson, H. P., & Fleming, J. E. E. (1975) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1975.tb00710.x · Cited by 1,413
Bujold, E., Roberge, S., Lacasse, Y., Bureau, M., Audibert, F., Marcoux, S., Forest, J.-C., & Giguère, Y. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181e9322a · Cited by 1,092
Irgens, H. U., Roberts, J. M., Reisæter, L., Irgens, L. M., & Lie, R. T. (2001) · BMJ · doi:10.1136/bmj.323.7323.1213 · Cited by 1,040
Subclassification of Preeclampsia
von Dadelszen, P., Magee, L. A., & Roberts, J. M. (2003) · Hypertension in Pregnancy · doi:10.1081/prg-120021060 · Cited by 763
Screening for fetal aneuploidies at 11 to 13 weeks
Nicolaides, K. H. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2637 · Cited by 642
Self-citationMake every mother and child count.
Spencer-Jones, J. (2005) · PubMed · Cited by 519
Challenges in the diagnosis of fetal non‐chromosomal abnormalities at 11–13 weeks
Syngelaki, A., Chelemen, T., Dagklis, T., Allan, L., & Nicolaides, K. H. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2642 · Cited by 498
Self-citation
Cited by
Point-of-care testing (POCT): Current techniques and future perspectives
Luppa, P. B., Müller, C., Schlichtiger, A., & Schlebusch, H. (2011) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2011.01.019 · Cited by 660
Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers
Akolekar, R., Syngelaki, A., Poon, L., Wright, D., & Nicolaides, K. H. (2013) · Fetal Diagnosis and Therapy · doi:10.1159/000341264 · Cited by 601
Self-citationScreening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation
Tan, M. Y., Syngelaki, A., Poon, L. C., Rolnik, D. L., O'Gorman, N., Delgado, J. L., Akolekar, R., Konstantinidou, L., Tsavdaridou, M., Galeva, S., et al. (2018) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.19112 · Cited by 438
Self-citationPrevention of perinatal death and adverse perinatal outcome using low‐dose aspirin: a meta‐analysis
Roberge, S., Nicolaides, K. H., Demers, S., Villa, P., & Bujold, E. (2013) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.12421 · Cited by 391
Self-citationTan, M. Y., Wright, D., Syngelaki, A., Akolekar, R., Cicero, S., Janga, D., Singh, M., Greco, E., Wright, A., Maclagan, K., et al. (2018) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.19039 · Cited by 385
Self-citationRoberge, S., Villa, P., Nicolaides, K., Giguère, Y., Vainio, M., Bakthi, A., Ebrashy, A., & Bujold, E. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000336662 · Cited by 381
Self-citationFirst trimester preeclampsia screening and prediction
Chaemsaithong, P., Sahota, D. S., & Poon, L. C. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.07.020 · Cited by 363
Turning the Pyramid of Prenatal Care
Nicolaides, K. H. (2011) · Fetal Diagnosis and Therapy · doi:10.1159/000324320 · Cited by 357
Self-citationHaas, D. M., Parker, C. B., Wing, D. A., Parry, S., Grobman, W. A., Mercer, B. M., Simhan, H. N., Hoffman, M. K., Silver, R. M., Wadhwa, P., et al. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.01.019 · Cited by 307
Ogge, G., Chaiworapongsa, T., Romero, R., Hussein, Y., Kusanovic, J. P., Yeo, L., Kim, C. J., & Hassan, S. S. (2011) · Journal of Perinatal Medicine · doi:10.1515/jpm.2011.098 · Cited by 299
Velauthar, L., Plana, M. N., Kalidindi, M., Zamora, J., Thilaganathan, B., Illanes, S. E., Khan, K. S., Aquilina, J., & Thangaratinam, S. (2014) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.13275 · Cited by 285
Early Prediction of Preeclampsia
Poon, L. C., & Nicolaides, K. H. (2014) · Obstetrics and Gynecology International · doi:10.1155/2014/297397 · Cited by 263
Self-citationThe competing risk approach for prediction of preeclampsia
Wright, D., Wright, A., & Nicolaides, K. H. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.11.1247 · Cited by 263
Self-citationProtocol for Measurement of Mean Arterial Pressure at 11-13 Weeks' Gestation
Poon, L. C. Y., Zymeri, N. A., Zamprakou, A., Syngelaki, A., & Nicolaides, K. H. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000335366 · Cited by 260
Self-citationCombined screening for preeclampsia and small for gestational age at 11-13 weeks
Poon, L. C. Y., Syngelaki, A., Akolekar, R., Lai, J., & Nicolaides, K. H. (2013) · Fetal Diagnosis and Therapy · doi:10.1159/000341712 · Cited by 204
Self-citationPre-eclampsia part 2: prediction, prevention and management
Chaiworapongsa, T., Chaemsaithong, P., Korzeniewski, S. J., Yeo, L., & Romero, R. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.103 · Cited by 132
Rezende, K. B. D. C., Bornia, R. G., Esteves, A. P. V. D. S., Cunha, A. J. L. A. D., & Amim Junior, J. (2016) · Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health · doi:10.1016/j.preghy.2016.08.229 · Cited by 37
Metadata
- Authors
- Akolekar, R., Syngelaki, A., Sarquis, R., Zvanca, M., & Nicolaides, K. H.
- Venue
- Prenatal Diagnosis
- Publisher
- Wiley
- Published
- 2011-01
- Volume
- 31
- Issue
- 1
- Pages
- 66-74
- ISSN
- 0197-3851 (ISSN-L)
- 1097-0223
- OpenAlex
- W1996307378
- Cited by
- 444
- References
- 39
- FWCI
- 58.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.